Pharmeasy IPO GMP (API Holdings), Pharmeasy Grey Market Premium
Know about Pharmeasy IPO (API Holdings IPO): Pharmeasy IPO GMP (Pharmeasy Grey Market Premium), Pharmeasy IPO Date, Pharmeasy IPO Review, Pharmeasy IPO Benefits & Risks. We will update Pharmeasy GMP daily. Also, all information related to Pharmeasy IPO like price band, all dates, issue size and retail parts etc. All the important information about Pharmeasy IPO is given below.
Pharmeasy IPO (API Holdings IPO)
API Holdings is the parent company of PharmEasy. API Holdings Limited is India's largest online healthcare platform (based on GMV of products and services sold as of 31 March 2021). The IPO of Pharmeasy Ltd is expected in the year 2022. Pharmeasy Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs - crore through IPO (Initial public offering).
Pharmeasy IPO will open in 2022 and close in 2022. The price band of the Pharmeasy IPO is ₹- to ₹-. Pharmeasy Ltd is looking to raise around ₹- crores through an initial public offering (IPO). Pharmeasy IPO QIB quota is 75%, NII quota is 15% and RII quota is 10%. Pharmeasy's IPO listing date is - 2022. You can know about Pharmeasy Limited IPO GMP (Grey Market Premium) below.
Pharmeasy has given bad financial performance. The company has made a loss of ₹125 crores in the financial year 2021 (31 March 2021). Pharmeasy IPO Size is ₹6,200 crores. In this IPO, all equity shares will be sold under fresh issue. The IPO of Pharmeasy will be listed on NSE and BSE. Pharmeasy's IPO face value is ₹- per equity share.
We will talk about Pharmeasy's financial, benefits, and risks of investing in the company.
Read About
What is Pharmeasy IPO GMP Today?
Pharmeasy IPO GMP is ₹-.
What is the Pharmeasy IPO Date?
Pharmeasy's IPO Opening date is April 2022.
What is Pharmeasy IPO Expected Return?
Pharmeasy IPO Expected Returns is approx -%.
About API Holdings Limited
API Holdings is India's largest digital healthcare platform (based on GMV of products and services sold). The company operates an integrated, end-to-end business addressing the healthcare needs of consumers through technology and fulfillment capabilities. The technology platform created by the company aims to provide every stakeholder with the health value-chain benefits of an interconnected network.
API Holdings works closely with consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors and clinics, and diagnostic laboratories. The company has built a connected ecosystem with a nationwide presence. The company's platforms are also offering their services in major cities and rural areas of India.
The company has the following Business and Brands:
Akanamedo
Akanamedo is India's largest hospital-focused supply chain platform. Akanamedo enables hospitals to procure and optimize, streamline consumption, and monitor consumption using a cloud-based technology platform, national infrastructure, and an exhaustive product basket.
Docon
Docon is India's first EMR platform. Through Docon, Doctor enables better patient care through the company's virtual clinic services.
FarmEasy
FarmEasy is an India's Largest Online Pharmacy Marketplace.
Retailio
Retailio is a platform which is one of the largest pharma platforms in India connecting pharmacies with wholesalers
Thyrocare
Thyrocare Technologies Limited is India's first and most advanced fully automated laboratory. Thyrocare has a strong presence in over 2000 cities/towns in India and internationally.
Important Links:
- API Holdings Website
- API Holdings (Pharmeasy) DRHP
- API Holdings RHP
Purpose of the offer
- To prepay/repay all or a part of the dues raised by the company.
- To meet general corporate objectives.
Pharmeasy GMP Today (Grey Market Premium)
[Note: Pharmeasy Ltd IPO GMP has not started yet]
| DATE | GMP | KOSTAK | Subject to Sauda |
|---|---|---|---|
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
| April | ₹ | ₹ | ₹ |
👉🏻 Check Other IPO GMP (Grey MarketPremium).
Pharmeasy IPO Date and Price Band Details
Pharmeasy IPO open date: April 2022, Closing date: April 2022, and Listing date: April 2022. The price band of Pharmeasy IPO is ₹- to ₹-per share. Pharmeasy's IPO issue size is Rs 6,200 crores. Pharmeasy Ipo retails portion is 10%, QIB Portion is 75%, and NII Portion is 15%.
| IPO Open: | 2022 |
| IPO Close: | 2022 |
| Listing Date: | 2022 |
| Listing On: | NSE & BSE |
| IPO Size: | Approx ₹6,200 Crores |
| Fresh Issue: | Approx ₹6,200Crores |
| Offer For Sale: | N/A |
| Price Band: | ₹- to ₹- per share |
| Face Value: | ₹10 per Equity share |
| QIB Portion: | 50% |
| Retail Portion: | 35% |
| NII Portion: | 15% |
| Employee Res: | Not Disclosed |
Pharmeasy IPO Market Lot & Size
Pharmeasy IPO's minimum lot size is - shares with ₹- application amount and the maximum lot size is - shares with ₹- application amount.
| Minimum Lot: | 01 |
| Minimum Lot Size: | - Shares |
| Minimum Amount: | ₹- |
| Maximum Lot: | 13 |
| Maximum Lot Size: | - Shares |
| Maximum Amount: | ₹- |
Pharmeasy IPO Allotment & Listing Date
| Ipo Opening Date: | 2022 |
| IPO Closing Date: | 2022 |
| Basis of Allotment: | 2022 |
| Refund Date: | 2022 |
| Credit to Demat Account: | 2022 |
| Listing Date: | 2022 |
Pharmeasy IPO Review
HappiestPost View: To be updated.
Brokerage Firm IPO Reviews
- Motilal Oswal: To be updated
- ICICI Securities: To be updated
- Capital Market: To be updated
- Ventura Securities Limited: To be updated
- GEPL Capital Ltd: To be updated soon
Pharmeasy Ipo Review
[Not rated yet (To be updated)]
Review For Listing Gain
Review For Short term
Review For Long term
Strength
- FarmEasy is India's largest online pharmacy marketplace and a well-known brand.
- The company has an experienced management team and directors.
- API Holdings owns a number of well-known businesses and brands, including Thyrocare, PharmEasy, Docan, Retelio and Acanamedo.
- The company has built a great ecosystem.
- The business of the company is scalable.
Risks
- The company's growth is dependent on the expansion of the digital healthcare industry.
- The financial track record of the company has not been special, in the financial year March-2021 the company had a loss of ₹ 644.83 crores.
- The company has experienced negative cash flow in the past and may continue to do so.
- Many other players are also present in the field of online pharmacy, due to which the company has to face competition.
- The impact of the COVID-19 pandemic on API Holdings is still unknown.
Pharmeasy Financials
Pharmeasy Financials(in Crores)
| Year | Total Assets | Revenue | Profit |
|---|---|---|---|
| 31 Mar 20 | ₹572.47 | ₹737.45 | -₹335.07 |
| 31 Mar 21 | ₹4,905.34 | ₹2,360.66 | -₹644.83 |
| 31 Jun 21 | ₹5,843.56 | ₹1,207.26 | -₹305.96 |
Promoters
The promoters of the company are:
- TPG
- Prosus
- Temasek
Contact Details of Pharmeasy
API Holdings Limited
902, 9th Floor, Raheja Plaza 1,
B-Wing, Opposite R-City Mall,
L.B.S. Marg, Ghatkopar West,
Mumbai 400 086, Maharashtra, India
Tel: +91 22625 56255
E-mail: corporatesecretarial@apiholdings.in
Website: www.apiholdings.in
Pharmeasy Lead Managers
- JM Financial Limited
- BofA Securities India Limited
- Kotak Mahindra Capital Company Limited
- Morgan Stanley India Company Private Limited
- Citigroup Global Markets India Private Limited
Pharmeasy IPO Registrars
Link Intime India Private Limited
C 101, 247 Park, L.B.S. Marg, Vikhroli (West),
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: apiholdings@linkintime.co.in
Website: www.linkintime.co.in
Conclusion
Looking at the financial position of API Holdings Limited, the financial track record of the Company has been poor. The company had a loss of ₹ 644.83 crore in the financial year March-2020. A big question is whether or not the company will be able to make profits for years to come. Our suggestion will be updated when Pharmeasy's IPO price band and other IPO details are announced. Pharmeasy Limited's financial details and other information are provided above.
Pharmeasy IPO FAQs
What is Pharmeasy IPO GMP Today?
Pharmeasy IPO GMP is ₹- as of today.
What is Pharmeasy's IPO Opening Date?
Pharmeasy IPO Opening date is 2022.
What is the Pharmeasy IPO Closing Date?
Pharmeasy IPO Closing date is 2022.
What is the Pharmeasy IPO Allotment date?
Pharmeasy IPO Allotment Date is 2022.
What is Pharmeasy IPO Listing Date?
Pharmeasy IPO Date is 2022.
What is Pharmeasy IPO Kostak Rate?
Pharmeasy IPO Kostak rate is ₹-.
What are Pharmeasy IPO Expected Returns?
Pharmeasy IPO Expected Returns is -%.
Read More:
For other important information related to the stock market and Grey Market Premium, Costak rate, you can click on the links given below.
How to Apply the Pharmeasy IPO with Zerodha?
1. Open your Zerodha kite app and visit the Account tab, then see for console and click on IPO.
2. If you are a Desktop user then Log in to Console on Zerodha Website. Go to Portfolio and Click on IPO.
3. You will see the IPO name "Pharmeasy Ltd".
4. Then, Click on Bid Button.
5. Then, Enter your UPI ID.
6. Then, Fill in Quantity and Price. (we recommend, you should choose the cutoff price.)
7. Then Submit the IPO Application Form.
8. Now go to your UPI App (PhonePe, Google Pay, etc) or BHIM App to Approve the mandate.
7. Then Submit the IPO Application Form.
8. Now go to your UPI App (PhonePe, Google Pay, etc) or BHIM App to Approve the mandate.
We hope you like this article about Pharmeasy IPO. If you have a query about Pharmeasy IPO Please post a comment.
Thanks For Visiting & Happy Investing.
0 Comments
We are waiting for your comments. 💙